K

Krebs Biochemicals and Industries Ltd
NSE:KREBSBIO

Watchlist Manager
Krebs Biochemicals and Industries Ltd
NSE:KREBSBIO
Watchlist
Price: 69.56 INR -1.99%
Market Cap: 1.5B INR

Net Margin
Krebs Biochemicals and Industries Ltd

-101%
Current
-53%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-101%
=
Net Income
-274.7m
/
Revenue
272.2m

Net Margin Across Competitors

No Stocks Found

Krebs Biochemicals and Industries Ltd
Glance View

Market Cap
1.5B INR
Industry
Pharmaceuticals

Krebs Biochemicals & Industries Ltd. engages in the manufacture and sale of pharmaceutical ingredients and intermediates. The company is headquartered in Hyderabad, Telangana. The firm manufactures various products, such as Androstenedione for use as Steroid Intermediate, and Lovastatin and Simvastatin for anti-cholesterol. The firm's products in either pilot or research and development stages include Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan and Phenylephrine. The firm has two manufacturing facilities one at Regadichelika, Nellore; and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam, Andhra Pradesh, India.

KREBSBIO Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-101%
=
Net Income
-274.7m
/
Revenue
272.2m
What is the Net Margin of Krebs Biochemicals and Industries Ltd?

Based on Krebs Biochemicals and Industries Ltd's most recent financial statements, the company has Net Margin of -101%.

Back to Top